Clinical Trials Browser

Completed × Neuroma, Acoustic × 90 days × Clear all

Neuroma, Acoustic

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT07305285 2025-12-26

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma

Phase NA Completed

160 enrolled

CNS

Facial Paralysis, Neuroma, Acoustic

Clinical Trials

Vestibular Schwannoma Organoids

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma